The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions

The following paper describes a collaboration between the Centers for Disease Control and Prevention and five Emerging Infections Program sites to develop a comprehensive population-based approach to monitoring human papillomavirus (HPV) vaccine impact on cervical cancer precursors and associated HP...

Full description

Saved in:
Bibliographic Details
Published in:Cancer causes & control 2012-02, Vol.23 (2), p.281-288
Main Authors: Hariri, Susan, Unger, Elizabeth R., Powell, Suzanne E., Bauer, Heidi M., Bennett, Nancy M., Bloch, Karen C., Niccolai, Linda M., Schafer, Sean, Markowitz, Lauri E.
Format: Article
Language:English
Subjects:
Adenocarcinoma
Adenocarcinoma - immunology
Adenocarcinoma - prevention & control
Adolescent
Adult
Biomedical and Life Sciences
Biomedicine
Cancer Research
Cancer screening
Cervical cancer
Cervical intraepithelial neoplasia
Cervical Intraepithelial Neoplasia - immunology
Cervical Intraepithelial Neoplasia - prevention & control
Cervical Intraepithelial Neoplasia - virology
Cervix
Disease control
Epidemiology
Female
Genotype
Genotypes
Hematology
Human papillomavirus
Humans
Infection
Infections
Labor standards
Lesions
Neoplasia
Oncology
Original Paper
Papillomaviridae - immunology
Papillomavirus Vaccines - immunology
Pilot Projects
Precancerous Conditions - immunology
Precancerous Conditions - prevention & control
Prospective Studies
Public Health
Reporting standards
Specimens
Uterine Cervical Neoplasms - immunology
Uterine Cervical Neoplasms - prevention & control
Uterine Cervical Neoplasms - virology
Vaccination
Vaccines
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The following paper describes a collaboration between the Centers for Disease Control and Prevention and five Emerging Infections Program sites to develop a comprehensive population-based approach to monitoring human papillomavirus (HPV) vaccine impact on cervical cancer precursors and associated HPV genotypes. The process of establishing this novel monitoring system is described, and development details such as enumeration of sources for reporting cervical intraepithelial neoplasia 2/3 and adenocarcinoma in situ, approaches to case ascertainment, electronic reporting, and HPV typing are outlined. Implementation of a feasible and sustainable surveillance system for HPV-associated cervical precancers will enable evaluation of the direct impact of HPV vaccination.
ISSN:0957-5243
1573-7225
DOI:10.1007/s10552-011-9877-6